메뉴 건너뛰기
Heart
Volumn 101, Issue 14, 2015, Pages 1085-1086
Mortality from myocardial infarction in chronic obstructive pulmonary disease: Minding and mending the 'gap'
Author keywords

[No Author keywords available]
Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUTICASONE FUROATE PLUS VILANTEROL; PLACEBO;
EID: 84934295505     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-307739     Document Type: Editorial
Times cited : (4)
References (8)
  • 1
    • 77956979987 scopus 로고    scopus 로고
    • Mortality in COPD: Causes, risk factors, and prevention
    • Berry CE, Wise RA. Mortality in COPD: causes, risk factors, and prevention. COPD 2010;7:375-82.
    • (2010) COPD , vol.7 , pp. 375-382
    • Berry, C.E.1    Wise, R.A.2
  • 2
    • 84874986674 scopus 로고    scopus 로고
    • Cardiovascular disease in COPD: Mechanisms
    • Maclay JD, MacNee W. Cardiovascular disease in COPD: mechanisms. Chest 2013;143:798-807.
    • (2013) Chest , vol.143 , pp. 798-807
    • Maclay, J.D.1    MacNee, W.2
  • 3
    • 84984596891 scopus 로고    scopus 로고
    • Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
    • Andell P, Koul S, Martinsson A, et al. Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. Open Hear 2014;1:e000002.
    • (2014) Open Hear , vol.1
    • Andell, P.1    Koul, S.2    Martinsson, A.3
  • 4
    • 84862017118 scopus 로고    scopus 로고
    • The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction
    • Stefan MS. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction. CHEST J 2012;141:1441.
    • (2012) CHEST J , vol.141 , pp. 1441
    • Stefan, M.S.1
  • 5
    • 84934275549 scopus 로고    scopus 로고
    • Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease
    • Rothnie KJ, Smeeth L, Herrett E, et al. Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease. Heart 2015;101:1103-10.
    • (2015) Heart , vol.101 , pp. 1103-1110
    • Rothnie, K.J.1    Smeeth, L.2    Herrett, E.3
  • 6
    • 84888193925 scopus 로고    scopus 로고
    • Effect of β blockers on mortality after myocardial infarction in adults with COPD: Population based cohort study of UK electronic healthcare records
    • accessed 21 Mar 2015
    • Quint JK, Herrett E, Bhaskaran K, et al. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records. BMJ 2013;347:f6650. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3898388&tool=pmcentrez&rendertype=abstract (accessed 21 Mar 2015)
    • (2013) BMJ , vol.347
    • Quint, J.K.1    Herrett, E.2    Bhaskaran, K.3
  • 7
    • 84870921383 scopus 로고    scopus 로고
    • Association of chronic lung disease with treatments and outcomes patients with acute myocardial infarction
    • Enriquez JR, de Lemos JA, Parikh SV, et al. Association of chronic lung disease with treatments and outcomes patients with acute myocardial infarction. Am Heart J 2013;165:43-9.
    • (2013) Am Heart J , vol.165 , pp. 43-49
    • Enriquez, J.R.1    De Lemos, J.A.2    Parikh, S.V.3
  • 8
    • 84877088995 scopus 로고    scopus 로고
    • The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol
    • Vestbo J, Anderson J, Brook RD, et al. The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol. Eur Respir J 2013;41:1017-22.
    • (2013) Eur Respir J , vol.41 , pp. 1017-1022
    • Vestbo, J.1    Anderson, J.2    Brook, R.D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.